AVTE -93%(!) on phase-2b failure in PAH: https://www.globenewswire.com/news-release/2024/06/17/2899669/0/en/Aerovate-Therapeutics-Announces-24-Week-Topline-Results-from-the-Phase-2b-Portion-of-IMPAHCT-Evaluating-AV-101-for-the-Treatment-of-Pulmonary-Arterial-Hypertension.html